NOTCH1 and cancer: Nakajima and colleagues had described a galectin-3-dependent activation of Notch1 signaling in a system that models tumor cell/osteoblast and osteoclast interactions, critical events in the maintenance of bone metastasis found in different cancers, such as breast and prostate cancers.